Session » Biology and Pathology of Bone and Joint - Poster II

Date: Monday, November 14, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1094

A Dual Role of Bromodomain Containing 1 Protein in Rheumatoid Arthritis Synovial Fibroblasts

9:00AM-11:00AM: Abstract Number: 1101

Adalimumab:TNF Complexes Induce a Divergent Proteomic Profile in Human Osteoclast Precursors to That Resembling a Monocytic Cell

9:00AM-11:00AM: Abstract Number: 1096

Augmentation of Wnt Signaling By IL-1β in Fibroblast-like Synoviocytes

9:00AM-11:00AM: Abstract Number: 1105

Bone Metabolism in Rheumatic Diseases May be Affected By Free Fatty Acids

9:00AM-11:00AM: Abstract Number: 1107

Combining Scaffold-Free Cartilage Transplants to Controlled Gene Expression for Therapeutic Application in Rheumatic Disorders

9:00AM-11:00AM: Abstract Number: 1102

Differentiation of Spongiosa-Derived Mesenchymal Stromal Cells from Osteoporosis and Osteoarthritis Patients Are Influenced By Adipokines

9:00AM-11:00AM: Abstract Number: 1104

Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04755) As a Potential Topical Treatment for Chronic Tendinopathy

9:00AM-11:00AM: Abstract Number: 1093

DNA Methylation Defines Joint Specific Differences in Synovial Fibroblasts from OA and RA Patients

9:00AM-11:00AM: Abstract Number: 1103

Gingival Tissue-Derived MSC Cells (GMSC) Suppress Osteoclastogenesis and Bone Erosion in Collagen-Induced Arthritis Thought CD73 Signal Pathway

9:00AM-11:00AM: Abstract Number: 1111

Huntingtin Interactin Protein 1 (HIP1) Regulates Receptor Tyrosine Kinases Mediated Activity and Cell Invasiness in Fibroblast-like Synoviocytes

9:00AM-11:00AM: Abstract Number: 1110

Inactive Rhomboid Family Member 2/Tnfα Convertase/Tnfα Pathway Is Essential to the Pathogenesis of Haemophilic Arthropathy

9:00AM-11:00AM: Abstract Number: 1095

Periarticular Bone Loss in Arthritis Is Induced By Autoantibodies Against Citrullinated Vimentin

9:00AM-11:00AM: Abstract Number: 1108

Protein Citrullinations By PAD Enzymes Promote Dendritic Cell Transdifferentiation into Osteoclast and Generate Targets for RA-Specific Antibodies

9:00AM-11:00AM: Abstract Number: 1099

Synovial Exosomes Induce Osteoclast Differentiation in Rheumatoid arthritis

9:00AM-11:00AM: Abstract Number: 1097

Tankyrase Regulates Osteoclastogenesis Via SH3BP2

9:00AM-11:00AM: Abstract Number: 1109

Targeting IL-8 and CXCR1/2 Abrogates RANKL- and ACPA-Mediated Osteoclastogenesis

9:00AM-11:00AM: Abstract Number: 1100

Tenofovir, a Nucleoside Analog Reverse Transcriptase Inhibitor for Treatment of HIV, Promotes Osteoclast Differentiation and Decreases Osteoblast Formation By a Mechanism Depending on ATP Release and Adenosine

9:00AM-11:00AM: Abstract Number: 1106

Test of the Spleen Tyrosine Kinase Inhibitor Fostamatinib in a Translational Joint Tissue Model Show Significant Effect on Bone, but Not on Synovial Tissue

9:00AM-11:00AM: Abstract Number: 1098

ZCCHC6/TUT7 Negatively Regulates Osterix Activity and Influences Osteoblast-Mediated Regulation of Osteoclastogenesis

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].